Giulia M. Muraca

Giulia M. Muraca

Auto-generated profile, based on publicly available information

Giulia M. Muraca

Department of Obstetrics and Gynecology McMaster University Hamilton Ontario Canada

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2017 in JAMA
Verified
Journal Article
Open access
PDF file
SLSarka Lisonkova
Sarka Lisonkova
GMGiulia M. Muraca
Giulia M. Muraca
JPJayson Potts
Jayson Potts
JLJessica Liauw
Jessica Liauw
WCWee-Shian Chan
Wee-Shian Chan
KLKenneth I. Lim
Kenneth I. Lim
Quiz Ref ID The age-adjusted prevalence of obesity among US women increased from 15.8% in 1960 to 40.4% in 2014.1,2 In 2014, half of pregnant women were either overweight (25.6%) or obese (24.8%).3 Overweight and obesity are associated with elevated risks of preterm birth, large-for-gestational-age live birth, macrosomia, shoulder dystocia, congenital anomalies, birth injury, stillbirth, cerebral palsy, and neonatal and infant death,4-11 while underweight is associated with preterm birth, small-for-gestational-age birth, and neonatal intensive care unit admission.11 Less is known about the association between body mass index (BMI) and potentially life-threatening maternal morbidity. Some studies have shown an association between obesity and pregnancy complications including hypertension in pregnancy and preeclampsia, gestational diabetes, thromboembolism, and cesarean delivery,4,11-15 although 1 study suggested that the overall risk of severe maternal morbidity does not increase with BMI.11

30 May 2017 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
SLSarka Lisonkova
Sarka Lisonkova
JPJayson Potts
Jayson Potts
GMGiulia M Muraca
Giulia M Muraca
NRNeda Razaz
Neda Razaz
YSYasser Sabr
Yasser Sabr
MKMichael S Kramer
Michael S Kramer
One of the United Nations’ Millennium Development Goals of 2000 was to reduce maternal mortality by 75% in 15 y; however, this challenge was not met by many industrialized countries. As average maternal age continues to rise in these countries, associated potentially life-threatening severe maternal morbidity has been understudied. Our primary objective was to examine the associations between maternal age and severe maternal morbidities. The secondary objective was to compare these associations with those for adverse fetal/infant outcomes. This was a population-based retrospective cohort study, including all singleton births to women residing in Washington State, US, 1 January 2003–31 December 2013 (n = 828,269). We compared age-specific rates of maternal mortality/severe morbidity (e.g., obstetric shock) and adverse fetal/infant outcomes (e.g., perinatal death). Logistic regression was used to adjust for parity, body mass index, assisted conception, and other potential confounders. We compared crude odds ratios (ORs) and adjusted ORs (AORs) and risk differences and their 95% CIs. Severe maternal morbidity was significantly higher among teenage mothers than among those 25–29 y (crude OR = 1.5, 95% CI 1.5–1.6) and increased exponentially with maternal age over 39 y, from OR = 1.2 (95% CI 1.2–1.3) among women aged 35–39 y to OR = 5.4 (95% CI 2.4–12.5) among women aged ≥50 y. The elevated risk of severe morbidity among teen mothers disappeared after adjustment for confounders, except for maternal sepsis (AOR = 1.2, 95% CI 1.1–1.4). Adjusted rates of severe morbidity remained increased among mothers ≥35 y, namely, the rates of amniotic fluid embolism (AOR = 8.0, 95% CI 2.7–23.7) and obstetric shock (AOR = 2.9, 95% CI 1.3–6.6) among mothers ≥40 y, and renal failure (AOR = 15.9, 95% CI 4.8–52.0), complications of obstetric interventions (AOR = 4.7, 95% CI 2.3–9.5), and intensive care unit (ICU) admission (AOR = 4.8, 95% CI 2.0–11.9) among those 45–49 y. The adjusted risk difference in severe maternal morbidity compared to mothers 25–29 y was 0.9% (95% CI 0.7%–1.2%) for mothers 40–44 y, 1.6% (95% CI 0.7%–2.8%) for mothers 45–49 y, and 6.4% for mothers ≥50 y (95% CI 1.7%–18.2%). Similar associations were observed for fetal and infant outcomes; neonatal mortality was elevated in teen mothers (AOR = 1.5, 95% CI 1.2–1.7), while mothers over 29 y had higher risk of stillbirth. The rate of severe maternal morbidity among women over 49 y was higher than the rate of mortality/serious morbidity of their offspring. Despite the large sample size, statistical power was insufficient to examine the association between maternal age and maternal death or very rare severe morbidities. Maternal age-specific incidence of severe morbidity varied by outcome. Older women (≥40 y) had significantly elevated rates of some of the most severe, potentially life-threatening morbidities, including renal failure, shock, acute cardiac morbidity, serious complications of obstetric interventions, and ICU admission. These results should improve counselling to women who contemplate delaying childbirth until their forties and provide useful information to their health care providers. This information is also useful for preventive strategies to lower maternal mortality and severe maternal morbidity in developed countries.

6 April 2021 in Obstetrics & Gynecology
Verified
Journal Article
Open access
KJK. S. Joseph
K. S. Joseph
ABAmélie Boutin
Amélie Boutin
SLSarka Lisonkova
Sarka Lisonkova
GMGiulia M. Muraca
Giulia M. Muraca
NRNeda Razaz
Neda Razaz
ESEnrique Schisterman
Enrique Schisterman
Rigorous studies carried out by the National Center for Health Statistics show that previously reported increases in maternal mortality rates in the United States were an artifact of changes in surveillance. The pregnancy checkbox, introduced in the revised 2003 death certificate and implemented by the states in a staggered manner, resulted in increased identification of maternal deaths and in reported maternal mortality rates. This Commentary summarizes the findings of the National Center for Health Statistics reports, describes temporal trends and the current status of maternal mortality in the United States, and discusses future concerns. Although the National Center for Health Statistics studies, based on recoding of death certificate information (after excluding information from the pregnancy checkbox), showed that crude maternal mortality rates did not change significantly between 2002 and 2018, age-adjusted analyses show a temporal reduction in the maternal mortality rate (21% decline, 95% CI 13–28). Specific causes of maternal death, which were not affected by the pregnancy checkbox, such as preeclampsia, showed substantial temporal declines. However, large racial disparities continue to exist: Non-Hispanic Black women had a 2.5-fold higher maternal mortality rate compared with non-Hispanic White women in 2018. This overview of maternal mortality underscores the need for better surveillance and more accurate identification of maternal deaths, improved clinical care, and expanded public health initiatives to address social determinants of health. Challenges with ascertaining maternal deaths notwithstanding, several causes of maternal death (unaffected by surveillance artifacts) show significant temporal declines, even though there remains substantial scope for preventing avoidable maternal death and reducing disparities.

1 September 2014 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Closed access
GMGiulia M. Muraca
Giulia M. Muraca
KJK.S. Joseph
K.S. Joseph

9 April 2008 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
NONancy F. Olivieri
Nancy F. Olivieri
GMGiulia M. Muraca
Giulia M. Muraca
AOAngela O’dOnnell
Angela O’dOnnell
APAnuja Premawardhena
Anuja Premawardhena
CFChristopher Fisher
Christopher Fisher
DWDavid J. Weatherall
David J. Weatherall
Summary: Haemoglobin E β‐thalassaemia is the commonest form of severe thalassaemia in many Asian countries, but little is known about its natural history, the reasons for its clinical diversity, or its optimal management. Despite its frequency, haemoglobin E β‐thalassaemia is often managed in an ill‐defined and haphazard way, usually by demand transfusion. We studied a cohort of Sri Lankan patients with haemoglobin E β‐thalassaemia over 5 years, and identified several genetic and environmental factors possibly contributing to the phenotypic diversity of the disorder. These included modifiers of haemoglobin F production, malaria and age‐related changes in adaptation to anaemia. Our findings suggest that in many patients, haemoglobin E β‐thalassaemia can be managed without transfusion, even with low haemoglobin levels. Age‐related changes in the pattern of adaptation to anaemia suggest that more cost‐effective approaches to management should be explored.

1 October 2005 in The Lancet
Verified
Journal Article
Closed access
APA Premawardhena
A Premawardhena
CFCa Fisher
Ca Fisher
NONf Olivieri
Nf Olivieri
SSS de Silva
S de Silva
MAM Arambepola
M Arambepola
DWDj Weatherall
Dj Weatherall